The Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2022 to 2027.
The Urinary Tract Obstruction Treatment Devices market is witnessing positive growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market during the forecast period from 2022-2027.
Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation (NYSE: BSX), Cook, Becton, Dickinson, and Company, Teleflex Incorporated (NYSE: TFX), Olympus (OCPNY), Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc. (NASDAQ: SWAV), ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker (NYSE: SYK), Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.
DelveInsight’s “Urinary Tract Obstruction Treatment Devices Market Insight & Forecast” report will offer an in-depth understanding of the Urinary Tract Obstruction Treatment Devices market, further benefiting the competitors or stakeholders operating in the Urinary Tract Obstruction Treatment Devices arena.
Urinary Tract Obstruction Treatment Devices
Urinary Tract Obstruction Treatment Devices are devices used to treat obstruction which occurs in the course of urine from the kidney to the urethra.
Interested to know more about the functioning of Urinary Tract Obstruction Treatment Devices– Visit @ Urinary Tract Obstruction Treatment Devices Operations & Working.
Urinary Tract Obstruction Treatment Devices Market Insights
Among all the regions, North America is expected to account for the largest share of the Global Urinary Tract Obstruction Treatment Devices market during the year 2021. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals are expected to aid in the growth of the North America Urinary Tract Obstruction Treatment Devices Market.
In the United States, high prostate cancer cases in the region increase the demand for urinary catheters as it causes difficulties in urination. For instance, as per the American Cancer Society 2021 statistics, about 248,530 new cases of prostate cancer are reported in the same year.
The rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for an increase in the usage of Urinary Tract Obstruction Treatment Devices. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US.
Moreover, according to the Canadian cancer society 2020 data, around 12,200 Canadians were suffering from bladder cancer in the year 2020.
As per the Canadian Urological Association guidelines 2021, globally, the prevalence of urolithiasis is steadily increasing, and though some regional variability exists, contemporary estimates report up to 10%-12% of men and 7%-8% of women now suffer from nephrolithiasis.
Moreover, according to the US Department of Health and Human Services 2021, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted.
Another factor responsible for the growth of the Urinary Tract Obstruction Treatment Devices market is the launch of new products in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US.
Thus, these factors are projected to contribute to the Urinary Tract Obstruction Treatment Devices market during the forecasted period.
Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Urinary Tract Obstruction Treatment Devices market during the forecast period.
To read more about why North America is leading the market growth in the Urinary Tract Obstruction Treatment Devices market, get a snapshot of the Urinary Tract Obstruction Treatment Devices market report.
Urinary Tract Obstruction Treatment Devices Market Dynamics
The Urinary Tract Obstruction Treatment Devices market is witnessing a growth in product demand owing to various reasons. The key factor includes the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others across the globe.
The most common causes of urinary obstruction are calculi, blood clots, tumors, or sloughed papilla. These obstructions present acutely, leading to severe renal colic with flank pain, hematuria, nausea, vomiting, and fever.
As per The Urology Foundation 2022, the incidence of benign prostatic hyperplasia (BPH), was estimated to increase from 50% among men between the ages of 50 and 60 years to 90% for men older than 80 years of age. Some men experience a sudden onset of the inability to pass urine (known as acute retention).
According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).
According to the National Kidney Foundation 2021, over half a million people go to emergency rooms for kidney stone problems every year.
Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, and less consumption of water can also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a higher risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities will also contribute to the Urinary Tract Obstruction Treatment Devices market growth.
As per the World Health Organization (WHO) 2021 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies, obese people develop more uric acid stones and calcium oxalate stones, which further hinder the normal passing of urine from the body.
Also, the aging population is more prone to the risk of end-stage renal failure. As per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Therefore, as the aging population increases, there will be more prevalence of urolithiasis, which will eventually boost the demand for Urinary Tract Obstruction Treatment Devices which will drive the growth of the Global Urinary Tract Obstruction Treatment Devices market.
However, certain factors such as the high cost of devices and the adverse events may be certain limiting factors to the Urinary Tract Obstruction Treatment Devices market growth.
Covid 19 Impact Analysis
The outbreak of the COVID-19 pandemic caused a significant decrease in emergency department visits. Moreover, there was a delay in outpatient clinic appointments which pushed the need for virtual or telephone clinics. Due to a lack of in-hospital beds, anesthesia or procedural slots, and healthcare professionals, these changes created a significant backlog in the treatment, thereby creating a negative impact on the Global Urinary Tract Obstruction Treatment Devices market.
To discuss the short/long-term impact of COVID-19, get a snapshot of the report Urinary Tract Obstruction Treatment Devices market assessment.
Recent Breakthroughs in Urinary Tract Obstruction Treatment Devices Market:
- In March 2021, Boston Scientific acquired Lumenis in a $1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urinary Tract Obstruction Treatment Devices market.
- In March 2021, Dornier MedTech GmbH became the world’s first integrated urology company to be certified by the European Union’s Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier’s Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS™, a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.
- In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
- In 2019, Shockwave Medical Inc. received breakthrough device designation for its intravascular lithotripsy (IVL) therapy, used for lithotripsy and was long used to eliminate kidney stones.
Key Players Proactively Working In the Urinary Tract Obstruction Treatment Devices Market
Key Urinary Tract Obstruction Treatment Devices companies involved in manufacturing and production are making significant growth in the advancement of these devices. To boost their market position, they also engage in mergers and acquisitions. Some of the key Urinary Tract Obstruction Treatment Devices companies operating actively in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.
Scope of the Urinary Tract Obstruction Treatment Devices Market Report:
- Geography Covered: Global
- Study Period: 2022-2027
- Key Urinary Tract Obstruction Treatment Devices Companies: B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.
- Market Segmentation by Product: Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others
- Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, Others
- Market Segmentation by Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Table of Contents
1 | Report Introduction |
2 | Executive Summary |
3 | Regulatory and Patent Analysis |
4 | Key Factors Analysis |
5 | Urinary Tract Obstruction Treatment Devices Porter’s Five Forces Analysis |
6 | COVID-19 Impact Analysis on Urinary Tract Obstruction Treatment Devices Market |
7 | Urinary Tract Obstruction Treatment Devices Market Layout |
8 | Urinary Tract Obstruction Treatment Devices Global Company Share Analysis – Key 3-5 Companies |
9 | Urinary Tract Obstruction Treatment Devices Companies and Product Profiles |
10 | Project Approach |
11 | KOL Views |
12 | DelveInsight Capabilities |
13 | Disclaimer |
To understand key companies related to the Urinary Tract Obstruction Treatment Devices Market, get a snapshot of the Urinary Tract Obstruction Treatment Devices Regulatory and Patent Analysis.
Key Takeaways from the Urinary Tract Obstruction Treatment Devices Market Report:
- Urinary Tract Obstruction Treatment Devices Market size analysis for the current market size (2020) and market forecast for five years (2021-2026)
- The effect of the COVID-19 pandemic on the Urinary Tract Obstruction Treatment Devices market is significant. Our experts closely watch the Urinary Tract Obstruction Treatment Devices market to capture and analyze suitable indicators.
- The top key services/products/technology developments, mergers, acquisitions, partnerships, and joint ventures have happened over the last three years.
- Key Urinary Tract Obstruction Treatment Devices companies are dominating the Global Urinary Tract Obstruction Treatment Devices Market.
- Various opportunities are available for other competitors in the Urinary Tract Obstruction Treatment Devices Market space.
- What are the top-performing segments in 2020 and how these segments are expected to perform in 2026?
- Which are the top-performing regions/countries in the current Urinary Tract Obstruction Treatment Devices market scenario?
- Which regions and countries should companies have focussed on opportunities for the growth of the Urinary Tract Obstruction Treatment Devices market in the future?
Learn More About DelveInsight Report Offerings:
Asthma Diagnostic Devices Market
“DelveInsight’s ‘Asthma Diagnostic Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report offers an in-depth understanding of Asthma Diagnostic Devices, market drivers and barriers, the historical and forecasted market trends, and key companies involved such as Medline Industries, Siemens Process Instrumentation, Smiths Medical (SMGZY), Vyaire Medical, Becton, Dickinson and Company (BDX), Nihon Kohden Corporation (NHNKY), Vitalograph, Circassia Limited (CIR), Intermedial Limited, and others.
Chronic Obstructive Pulmonary Disease Treatment Devices Market
“DelveInsight’s ‘Chronic Obstructive Pulmonary Disease Treatment Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report offers an in-depth understanding of Chronic Obstructive Pulmonary Disease Treatment Devices, market drivers and barriers, the historical and forecasted market trends, and key companies involved such as GlaxoSmithKline plc (GSK), AstraZeneca (AZN), 3M, GF HEALTH PRODUCTS, Novartis AG (NVS), Merck & Co. (MRK), Koninklijke Philips N.V (PHG), Sunovion Pharmaceuticals Inc (SEPR), Smiths Medical (SMGZY), Baxter (BAX), and others.
Airway Management Devices Market
Global Airway Management Devices Market was valued at USD 1.51 billion in 2020, growing at a CAGR of 6.20% during the forecast period from 2021 to 2026, to reach USD 2.35 billion by 2026. The report delivers an in-depth understanding of the Airway Management Devices, historical and forecasted epidemiology, and key companies involved in pipelines such as Smiths Medical PLC (SMGZY), Narang Medical Limited, Intersurgical Ltd (ISRG), Teleflex Incorporated (TFX), Stryker Corporation (SYK), Medtronic PLC (MDT), and others.
“DelveInsight’s ‘Cough Assist Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, drivers, barriers, and key companies involved such as Koninklijke Philips N.V (PHG), Percussionaire Corp, Emerson (EMR), Hill Rom (HRC), Dima Italia SRL, and others.
Global Pulse Oximeters Market was valued at USD 1.9 billion in 2020, growing at a CAGR of 10.13% during the forecast period from 2021 to 2026, to reach USD 3.3 billion by 2026. The report delivers an in-depth understanding of Pulse Oximeters and the historical and forecasted Pulse Oximeters market trends, drivers, barriers, and key companies involved such as Medtronic (MDT), Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation (OMRNY), Meditech Equipment Co, and others
Peripherally Inserted Central Catheters (PICC) Devices Market
“DelveInsight’s ‘Peripherally Inserted Central Catheters (PICC) Devices Market Insight, Competitive Landscape and Market Forecast, 2026′ report delivers an in-depth understanding of Peripherally Inserted Central Catheters (PICC) Devices and the historical and forecasted Peripherally Inserted Central Catheters (PICC) Devices market trends, drivers, barriers, and key companies involved such as AngioDynamics Inc. (ANGO), B. Braun Melsungen AG, Becton, Dickinson and Company (BDX), Teleflex Incorporated (TFX), Argon Medical Devices, and others.
Chronic Hemodialysis Catheter Market
“DelveInsight’s ‘Chronic Hemodialysis Catheter Devices Market Insight, Competitive Landscape and Market Forecast, 2026′ report delivers an in-depth understanding of Chronic Hemodialysis Catheter Devices and the historical and forecasted Chronic Hemodialysis Catheter Devices market trends, drivers, barriers, and key companies involved such as Nipro Medical Corporation, Nikkiso Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Baxter (BAX), AngioDynamics (ANGO), TORAY MEDICAL CO,.LTD., Meddtronic, and others.
Hemodialysis Catheter Devices Market
“DelveInsight’s ‘Hemodialysis Catheter Devices Market Insight, Competitive Landscape and Market Forecast, 2026′ report delivers an in-depth understanding of Hemodialysis Catheter Devices and the historical and forecasted Hemodialysis Catheter Devices market trends, drivers, barriers, and key companies involved.
Trending Healthcare Blogs by DelveInsight:
- Treatment-resistant Hypertension: Insights into the Challenges and Solutions
- Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU in 2022
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Get in touch with our team to get more detailed insights into how the MedTech Market is expected to advance in the coming years and formulate innovative business solutions at MedTech Consulting Solutions.
Contact Us
Kritika Rehani
+1(919)321-6187
www.delveinsight.com